NANOBIOTIX (EPA:NANO) | WebDisclosure

Basculer en Français

10130	Companies
207782	Keywords
137827	Articles
110082	Press releases

Home
Companies
NANOBIOTIX

PRESS RELEASE

published on 10/31/2025 at 08:00, 5 months ago

NANOBIOTIX Announces Strategic Royalty Monetization Agreement With Healthcare Royalty for up to $71 Million and Extends Cash Runway Toward Long-Term Growth
Nanobiotix announces $71M strategic royalty monetization agreement with Healthcare Royalty, extending cash runway and enabling long-term growth in cancer treatment

Cancer Treatment HealthCare Royalty Financial Agreement NANOBIOTIX Royalty Monetization
BRIEF

published on 10/01/2025 at 22:20, 5 months 29 days ago

NANOBIOTIX révèle des résultats prometteurs d'une étude de phase 1 pour le traitement du cancer de l'œsophage

Étude De Phase 1 Radiothérapie JNJ-1900 (NBTXR3) Cancer De L'œsophage Événements Indésirables
BRIEF

published on 10/01/2025 at 22:20, 5 months 29 days ago

NANOBIOTIX Reveals Promising Phase 1 Study Results for Esophageal Cancer Treatment

Phase 1 Study Radiotherapy Adverse Events JNJ-1900 (NBTXR3) Esophageal Cancer
PRESS RELEASE

published on 10/01/2025 at 22:15, 5 months 29 days ago

NANOBIOTIX Announces First Data From Phase 1 Study Evaluating JNJ-1900 (NBTXR3) for Patients With Esophageal Cancer
Nanobiotix announces first data from Phase 1 study evaluating JNJ-1900 (NBTXR3) for patients with esophageal cancer. Results presented at ASTRO 2025 Annual Meeting

NANOBIOTIX Phase 1 Study JNJ-1900 Esophageal Cancer ASTRO
PRESS RELEASE

published on 10/01/2025 at 22:15, 5 months 29 days ago

NANOBIOTIX annonce les premières données de Phase 1 évaluant JNJ-1900 (NBTXR3) chez des patients atteints de cancer de l’œsophage
Nanobiotix annonce les premières données de phase 1 évaluant JNJ-1900 (NBTXR3) chez des patients atteints de cancer de l’œsophage. Taux de contrôle de la maladie de 85% et taux de réponse objective de 69%

NANOBIOTIX Phase 1 JNJ-1900 ASTRO Cancer De L’œsophage
PRESS RELEASE

published on 09/30/2025 at 22:27, 6 months ago

RAPPORT FINANCIER SEMESTRIEL
BRIEF

published on 09/30/2025 at 22:20, 6 months ago

Nanobiotix: Financial results and clinical progress in the first half of 2025

Financial Results Biotechnology NANOBIOTIX Johnson & Johnson JNJ-1900
BRIEF

published on 09/30/2025 at 22:20, 6 months ago

Nanobiotix : Bilan financier et avancées cliniques au 1er semestre 2025

Résultats Financiers Biotechnologie NANOBIOTIX Johnson & Johnson JNJ-1900
PRESS RELEASE

published on 09/30/2025 at 22:15, 6 months ago

NANOBIOTIX fait le point sur ses activités et publie ses résultats financiers pour le premier semestre 2025
Nanobiotix fait le point sur ses activités et publie ses résultats financiers pour le premier semestre 2025, marqué par le développement clinique de JNJ-1900 et une gestion financière rigoureuse

Résultats Financiers Développement Clinique Gestion Financière NANOBIOTIX JNJ-1900
PRESS RELEASE

published on 09/30/2025 at 22:15, 6 months ago

NANOBIOTIX Provides Business Update and Reports Half Year 2025 Financial Results
Nanobiotix provides business update & reports 2025 half year financial results. Highlights clinical development program & financial performance

Financial Results Financial Performance Business Update Clinical Development NANOBIOTIX

Accesswire

Published on 03/31/2026 at 15:15, 20 minutes ago

Datavault AI and Coppercore Inc. Announce Tokenization of High-Grade Copper Resources into Coppercoin(TM)
Published on 03/31/2026 at 14:30, 1 hour 5 minutes ago

Sky Gold Advances High Life Cu-Au Porphyry Target with Strong Surface Gold Results Ahead of Upcoming Drill Program
Published on 03/31/2026 at 14:30, 1 hour 5 minutes ago

Hillcrest Provides Update on Shares for Debt Offering
Published on 03/31/2026 at 14:00, 1 hour 35 minutes ago

Horizon Aircraft to Report Third Quarter 2026 Results and Provide a Business Update on April 14, 2026
Published on 03/31/2026 at 14:00, 1 hour 35 minutes ago

Hi-View Resources Inc. Has Acquired the Company's Stallion Project

View all ACCESSWIRE

EQS Group

Published on 03/31/2026 at 15:27, 8 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Schroders plc
Published on 03/31/2026 at 15:27, 8 minutes ago

The Vanguard Group, Inc.: Picton Property Income Limited
Published on 03/31/2026 at 15:26, 9 minutes ago

The Vanguard Group, Inc.: NCC Group plc
Published on 03/31/2026 at 15:25, 10 minutes ago

TeamViewer Surpasses One Million AI Sessions in Major Adoption Milestone
Published on 03/31/2026 at 15:24, 11 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Just Group plc

Les Echos

Published on 03/31/2026 at 15:00, 35 minutes ago

Statement of transactions in own shares from March 23, 2026 to March 27, 2026
Published on 03/31/2026 at 15:00, 35 minutes ago

Déclaration des transactions sur actions propres réalisées du 23/03/2026 au 27/03/2026
Published on 03/31/2026 at 10:56, 4 hours 39 minutes ago

Recticel Group ontvangt EcoVadis-zilveren medaille en behoudt CDP ‘A’-rating in dubbele overwinning voor duurzaamheidsprestaties
Published on 03/31/2026 at 10:56, 4 hours 39 minutes ago

Recticel Group receives EcoVadis Silver Medal and retains CDP ‘A’ rating in double win for sustainability performance
Published on 03/31/2026 at 08:45, 6 hours 50 minutes ago

Air Liquide successfully completes the Sustainability dimension of its ADVANCE Strategic Plan

View all LES ECHOS COMFI WIRE